IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#2893
Positioning
Market Dominance
Finance, Insurance, And Real Estate
Banking
$5.5B
Michael J. Levitt
Core Scientific, Inc. provides net carbon-neutral blockchain infrastructure and digital asset mining solutions in North America. It operates in two segments, Equipment Sales and Hosting. It offers blockchain hosting services with deployment and provide power, racks, proprietary thermodynamic management, redundant connectivity, and 24/7 security.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$SII SPROTT INC. | 75 | 91 | 87 | 98 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$PUK PRUDENTIAL PLC | 73 | 88 | 97 | 80 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$NMR NOMURA HOLDINGS INC | 72 | 81 | 92 | 87 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$PSLV Sprott Physical Silver Trust | 69 | 82 | 80 | 98 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$UFCS UNITED FIRE GROUP INC | 68 | 81 | 93 | 76 | 5.0x | 3.5x | 13.2% | 4.1% | 99.9% | 14.7% | 11.1% | 9.2% | 2.1% | 16.0x | $775M | VS | |
$SLF SUN LIFE FINANCIAL INC | 68 | 83 | 95 | 63 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$CBOE Cboe Global Markets, Inc. | 68 | 75 | 63 | 77 | 21.3x | 15.7x | 24.0% | 13.7% | 41.7% | 32.4% | 26.4% | 8.2% | 1.1% | 30.0x | $25.7B | VS | |
$VTMX Vesta Real Estate Corporation, S.A.B. de C.V. | 67 | 69 | 77 | 80 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$PHYS Sprott Physical Gold Trust | 67 | 64 | 82 | 91 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$GLDM World Gold Trust | 66 | 54 | 85 | 92 | 11.3x | 11.3x | - | 20.9% | 100.0% | 97.1% | 554.8% | -19.0% | 0.0% | - | $32.0B | VS | |
$CORZ Core Scientific, Inc./tx | 44 | 33 | 26 | 79 | - | - | 82.7% | -41.7% | 5.3% | -50.3% | -279.9% | -42.5% | 0.0% | - | $5.5B | ||
| SECTOR BENCH | - | - | - | - | - | 11.9x | 7.8x | 9.0% | 1.3% | 77.7% | 18.1% | 21.9% | 10.7% | 2.0% | 0.5x | - | REF |
Core Scientific, Inc./tx (CORZ) receives a "Reduce" rating with a composite score of 44.4/100. It ranks #2893 out of 7,333 stocks in our coverage universe and carries a 2-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
Outperforming peers — winners tend to keep winning over 3-12 months
Expensive relative to fundamentals — limited margin of safety
Weak fundamentals — higher risk of value trap
High volatility — wider range of outcomes increases timing risk
Aggressive spending — empire-building risk, dilutive growth
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Finance, Insurance, And Real Estate sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
No analyst ratings for CORZ.
View All Ratings| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 33 | 56 | -23DRAG |
| MOMENTUM | 79 | 87 | -8DRAG |
| VALUATION | 26 | 17 | +9ALPHA |
| INVESTMENT | 35 | 59 | -24DRAG |
| STABILITY | 11 | 6 | +5NEUTRAL |
| SHORT INT | 43 | 41 | +2NEUTRAL |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROIC -7.5% vs WACC 8.8% (spread -16.3%)
GM 5% vs sector 78%, OM -50% vs sector 18%
Capital turnover 0.13x
Rev growth -43%, 5yr history
Interest coverage N/A
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
We rate Core Scientific, Inc./tx (CORZ) as a Reduce with a composite score of 44.4/100 at a current price of $17.83. The quantitative profile shows weakness across multiple dimensions, suggesting limited upside potential.
Core Scientific, Inc./tx holds a top-quartile position (#0 of 50) within the Finance, Insurance, And Real Estate sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 44.4/100 places it at rank #2893 in our full universe.
The near-term outlook is constructive, with revenue growing at -43% and momentum in the 79th percentile confirming positive market sentiment. The combination of strong top-line growth and favorable price dynamics suggests the company is executing well on its growth strategy.
No Moat
Very High
Poor
Fair Value
Returns on equity of 82.7% exceed cost of capital.
Positive momentum indicates institutional accumulation.
Stable competitive position in a defensive sector.
Below-average quality raises earnings sustainability concerns.
Vulnerability to macroeconomic shocks and interest rate volatility.
Core Scientific, Inc./tx represents a reduce based on multi-factor quantitative performance.
Core Scientific, Inc./tx receives a Reduce rating from our analysis, with a composite score of 44.4/100 and 2 out of 5 stars, ranking #2893 out of 7,333 stocks. CORZ's factor profile shows weakness across multiple dimensions, suggesting the stock may underperform going forward. Existing holders may want to consider trimming positions or tightening stop-losses.
CORZ's quality score of 33/100 is below average, suggesting challenges with profitability or capital efficiency. The company reports a return on equity of 82.7% (sector avg: 9.0%), gross margins of 5.3% (sector avg: 77.7%), net margins of -279.9% (sector avg: 21.9%). Investors should examine whether management is actively addressing these weaknesses or if they reflect structural industry headwinds.
CORZ registers a value score of just 26/100, suggesting the stock trades at a significant premium to its fundamental metrics. High-premium valuations like this require strong future execution to avoid multiple compression, and downside risk is elevated if growth disappoints.
Core Scientific, Inc./tx's investment score of 35/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of -42.5% vs. a sector average of 10.7% and a return on assets of -41.7% (sector: 1.3%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
CORZ shows strong momentum characteristics with a score of 79/100. The stock has been trending above key moving averages, indicating solid demand from institutional buyers. Revenue growth stands at -42.5% year-over-year, while a beta of 2.00 reflects its sensitivity to broader market moves. This level of momentum typically signals sustained investor confidence and favorable near-term price action.
Core Scientific, Inc./tx registers a low stability score of 11/100, indicating high volatility and potentially stressed financial conditions. Key stability metrics include a beta of 2.00. Stocks at this level carry elevated capital loss risk and may be unsuitable for conservative portfolios without careful risk management.
The short interest score of 43/100 for CORZ suggests somewhat elevated bearish positioning by institutional traders. Specific risk factors include high market sensitivity (beta: 2.00). With a $5.5B market cap (mid-cap), Core Scientific, Inc./tx may experience above-average volatility. Investors should consider whether the short thesis has merit or if it creates a potential short-squeeze opportunity.
Core Scientific, Inc./tx is a mid-cap company in the Finance, Insurance, And Real Estate sector, ranked #0 of 50 in its sector (100th percentile) and #2893 of 7,333 overall (61st percentile). Key comparisons include ROE of 82.7% exceeding the 9.0% sector median and operating margins of -50.3% below the 18.1% sector average. This top-quartile standing reflects exceptional competitive strength relative to Finance, Insurance, And Real Estate peers.
While CORZ currently exhibits a REDUCE profile, superior opportunities exist within the FINANCE, INSURANCE, AND REAL ESTATE sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Finance, Insurance, And Real Estate Alpha →Quant Factor Profile
Upgrade catalyst
Improvement in Stability (11) would have the largest impact on the composite score.
ROE 819% ABOVE SECTOR MEDIAN (FAVORABLE)
Gross Margin 93% BELOW SECTOR MEDIAN
Op. Margin 377% BELOW SECTOR MEDIAN
Above 50MA
37.18%
Net New Highs
+51081
Keefe Bruyette has increased its price target for Core Scientific (CORZ) to $25 from $19, maintaining an Outperform rating. This adjustment reflects Core Scientific's strategic shift from Bitcoin mining to High-Performance Computing (HPC) leasing, with the firm anticipating further deals and pipeline updates. BTIG also upgraded CORZ to Buy with a $23 price target, expecting the company to secure additional HPC colocation contracts in 2026.
Trivest Advisors Ltd has made a new investment of $6.56 million in Core Scientific (NASDAQ:CORZ), acquiring 365,500 shares. This positions Core Scientific as the 29th largest holding in Trivest’s portfolio, representing 0.2% of its total investments. Other institutional investors like Vanguard Group Inc., Situational Awareness LP, Geode Capital Management LLC, ORG Wealth Partners LLC, and State Street Corp have also increased their stakes in the company.
Core Scientific (NASDAQ:CORZ) is projected to release its Q4 2025 earnings before market open on Wednesday, February 25th, with analysts expecting a loss of ($0.27) per share and revenue of $118.4460 million. The company's stock has a market capitalization of $5.34 billion and a P/E ratio of 114.87, with various analysts issuing "Buy" or "Outperform" ratings and a consensus "Moderate Buy" rating. Hedge funds like Allworth Financial LP and Osaic Holdings Inc. have increased their stakes in Core Scientific.
Core Scientific, Inc. (CORZ) is highlighted by Keefe, Bruyette & Woods due to an attractive setup ahead of anticipated pipeline updates and new deals. The firm sees strong upside for CORZ, driven by expectations of significant hash rate growth which could lead to increased revenue and margin expansion. This positive outlook positions Core Scientific for potential valuation re-rating.
Core Scientific (NASDAQ: CORZ) is experiencing a promising rise in its stock valuation, trading up by 8.69% due to strategic shifts. The company is transitioning from traditional bitcoin mining to leasing high-performance computing resources, a move that analysts believe will lead to a higher price target. This reorientation is seen as a way to navigate potential regulatory tightening in the crypto market and capitalize on new opportunities, despite current profitability struggles.